197 related articles for article (PubMed ID: 8493436)
1. [Chronic viral hepatitis: current diagnosis and therapy].
Blum HE
Schweiz Rundsch Med Prax; 1993 Apr; 82(17):501-5. PubMed ID: 8493436
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of viral hepatitis].
Rambusch EG; Manns MP
Ther Umsch; 1998 Feb; 55(2):71-6, 78-9. PubMed ID: 9545847
[TBL] [Abstract][Full Text] [Related]
3. [Viral hepatitis A to E--diagnosis, clinical aspects and therapy].
Blum HE
Ther Umsch; 1994 Aug; 51(8):530-7. PubMed ID: 7940409
[TBL] [Abstract][Full Text] [Related]
4. [Hepatitis B and C: biology and molecular diagnosis].
Blum HE
Verh Dtsch Ges Pathol; 1994; 78():94-103. PubMed ID: 7534024
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
Riediger C; Berberat PO; Sauer P; Gotthardt D; Weiss KH; Mehrabi A; Merle U; Stremmel W; Encke J
Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
[TBL] [Abstract][Full Text] [Related]
6. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
[TBL] [Abstract][Full Text] [Related]
7. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients.
Fagiuoli S; Pevere S; Minniti F; Livi U; Caforio AL; Naccarato R; Chiaramonte M
Transplantation; 2003 Apr; 75(7):982-6. PubMed ID: 12698084
[TBL] [Abstract][Full Text] [Related]
8. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
Moulin V; Harzic M; Doll J; Dubeaux B; Ghnassia JC; Andrieu J
Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
[TBL] [Abstract][Full Text] [Related]
9. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
10. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and therapy of chronic viral hepatitis].
Heintges T; Niederau C; Mohr L; Hensel F; Häussinger D
Z Gastroenterol; 1996 Jul; 34(7):446-56. PubMed ID: 8928540
[TBL] [Abstract][Full Text] [Related]
12. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.
Di Martino V; Thevenot T; Colin JF; Boyer N; Martinot M; Degos F; Coulaud JP; Vilde JL; Vachon F; Degott C; Valla D; Marcellin P
Gastroenterology; 2002 Dec; 123(6):1812-22. PubMed ID: 12454838
[TBL] [Abstract][Full Text] [Related]
13. Coinfections with hepatitis g and/or c virus in hepatitis B-related chronic liver disease.
Pramoolsinsap C; Sirikulchayanonta V; Busakorn W; Poovorawan Y; Hirsch P; Theamboonlers A; Lerdverasirikul P
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):741-9. PubMed ID: 10928369
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia.
Abe K; Hayakawa E; Sminov AV; Rossina AL; Ding X; Huy TT; Sata T; Uchaikin VF
J Clin Virol; 2004 May; 30(1):57-61. PubMed ID: 15072755
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
16. Therapy for chronic viral hepatitis.
Alvarez F
Clin Invest Med; 1996 Oct; 19(5):381-8. PubMed ID: 8889278
[TBL] [Abstract][Full Text] [Related]
17. [Current diagnosis of viral hepatitis].
Blum HE
Praxis (Bern 1994); 1996 Nov; 85(47):1502-6. PubMed ID: 8984576
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
Pramoolsinsap C; Poovorawan Y; Sura T; Theamboonlers A; Busagorn N; Kurathong S
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943
[TBL] [Abstract][Full Text] [Related]
19. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
[TBL] [Abstract][Full Text] [Related]
20. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
